Stocktoria
RECURSION PHARMACEUTICALS, INC. RXRX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-04-16
RECURSION PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 17,310,162 | $129.8M | 3.28% |
| ARK Investment Management LLC | 40,212,769 | $123.5M | 7.61% |
| TWO SIGMA INVESTMENTS, LP | 4,066,315 | $12.5M | 0.77% |
| MILLENNIUM MANAGEMENT LLC | 2,612,277 | $8.0M | 0.49% |
| CITADEL ADVISORS LLC | 2,433,359 | $7.5M | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 2,400,605 | $7.4M | 0.45% |
| AQR CAPITAL MANAGEMENT LLC | 244,391 | $750,281 | 0.05% |
| Point72 Asset Management, L.P. | 46,300 | $142,141 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.